Abstract:Part of the National Placebo Initiative in Canada included public consultations, based on the belief that the views of the public should inform Canadian policy development on what constitutes appropriate placebo use. Public consultations took place nationally in 2003. A deliberative dialogue approach was used, or a structured discussion format designed to facilitate the consideration of complex issues and build consensus. The placebo debate was characterized as having 3 distinct approaches and each were explored. The first approach "Maximize Patient Protection" identified the need for experts to determine appropriate placebo use and that placebos should only be allowed under very restricted conditions. The second approach "Maximize Medical Knowledge" identified that placebos give essential information about the safety and efficacy of new drugs, and are appropriate when the rights, safety and well-being of research participants are ensured. The third approach "Maximize Patient Autonomy" identified that the current system of regulating placebo use is paternalistic and that patients should be able to define what is in their best interests and have more leeway to determine for themselves if they wish to participate in a placebo-controlled trial. Advantages and disadvantages of each approach were considered and feedback on what constitutes appropriate placebo use was sought. The major findings were that: PCTs were considered a valuable and acceptable part of advancing medical knowledge, research using placebos must be valid and justifiable; a patient-centred approach needs to be fostered; patient autonomy (choice) should be a first consideration and take clear precedence in trials of low to medium risk, patient protection (or health) may need to "trump" patient autonomy at higher levels of risk and/or patient vulnerability; placebos are not a violation of the duty of care as duty of care is best met by identifying a choice for patients, whenever a choice is available. These consultations clearly were not designed to produce conclusive evidence, but rather to provide some useful insights into what the public may think about placebo use; additional studies are indicated.

Placebo and the law of identification

Placebo Effects: Historical and Modern Evaluation

Placebo Effects and the Molecular Biological Components Involved

Nocebo: the power of suggestibility

The neurobiological underpinnings of placebo and nocebo effects

The Practical Importance of Understanding Placebo Effects and Their Role when Approving Drugs and Recommending Doses for Medical Practice

The powerful placebo effect: fact or fiction?

["Placebo effect", from personal convictions to collective representations: A psychosocial reading of a pharmacodynamic phenomenon]

Double blind: Double talk or are there ways to do better research

The placebo response. Recent research and implications for family medicine

What does the public think of placebo use? The Canadian experience

The Ethics of Placebo

The Role of Attention in Placebo and Nocebo Effects

[Placebo effect: a contribution of social psychology]

Placebo Response is Driven by UCS Revaluation: Evidence, Neurophysiological Consequences and a Quantitative Model

Placebo Tests for Causal Inference

Pain, placebo, and test of treatment efficacy: a narrative review

Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology

A Fictionalist Account of Open-Label Placebo

Neuropsychological mechanisms of observational learning in human placebo effects

A Review on the Placebo Effect